Chapter title |
Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges.
|
---|---|
Chapter number | 6 |
Book title |
Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract
|
Published in |
Advances in experimental medicine and biology, August 2016
|
DOI | 10.1007/978-3-319-41388-4_6 |
Pubmed ID | |
Book ISBNs |
978-3-31-941386-0, 978-3-31-941388-4
|
Authors |
Oliver Pech M.D., Ph.D., Oliver Pech |
Editors |
Marnix Jansen, Nicholas A. Wright |
Abstract |
Endoscopic therapy of early Barrett's neoplasia is nowadays the treatment of choice and recommended over surgery in most current guidelines. Recent data suggest radiofrequency ablation of low-grade intraepithelial neoplasia when confirmed by an expert pathologist. Endoscopic therapy of high-grade intraepithelial neoplasia and mucosal Barrett's adenocarcinoma consists of two steps: first endoscopic resection of all visible lesions, and second ablation of the remaining flat Barrett's mucosa to reduce the rate of recurrences and metachronous neoplasia. The preferred ablation method is radiofrequency ablation. In case of Barrett's adenocarcinoma with incipient submucosal invasion, endoscopic treatment can be considered curative when there are no further risk factors present. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 2 | 22% |
Other | 2 | 22% |
Professor > Associate Professor | 1 | 11% |
Unknown | 4 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Economics, Econometrics and Finance | 3 | 33% |
Unknown | 6 | 67% |